Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
about
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids SignalingTowards a personalized treatment in depression: endocannabinoids, inflammation and stress responseSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionTargeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative DisordersSimilar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environmentsEffects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seekingDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Endocannabinoid-mediated synaptic plasticity and addiction-related behaviorEndocannabinoid system: emerging role from neurodevelopment to neurodegeneration.CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.Cannabinoid CB₂ receptor-mediated regulation of impulsive-like behaviour in DBA/2 miceEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotineBrain CB₂ Receptors: Implications for Neuropsychiatric Disorders.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceEndocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.CB2: a cannabinoid receptor with an identity crisisDepression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptorsCannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.The endocannabinoid/endovanilloid system and depression.Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine DependenceCocaine withdrawal reduces group I mGluR-mediated long-term potentiation via decreased GABAergic transmission in the amygdalaRole of the endogenous cannabinoid system in nicotine addiction: novel insights.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.CB₂: therapeutic target-in-waitingDecreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development.Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.Elucidating cannabinoid biology in zebrafish (Danio rerio).
P2860
Q26777055-882F3FA4-EF00-43F8-8AF6-8A1C8D34984BQ26851511-A003F76B-18C2-47CA-B24C-F79C9644B2A6Q27010555-A6EE8EEA-2FB3-4748-9181-6318DB540FFAQ27014154-CA477376-9533-495A-87F4-AB21DE7F88DBQ28073952-227FE4F6-62A1-4CFB-821E-298A92F1FA35Q28384182-14B7CE29-F609-461A-9C53-C91639ED0D00Q28480387-33426AF5-E29F-43CE-AE46-59ECDE71EC57Q28540537-8BEB74DE-D0EE-4B8F-A462-079815B867BFQ29042501-101A66D5-2A53-42E6-9C0C-F1AB460DCCF3Q30391852-D34AF2B0-051F-4B28-B0F7-07D9CABE7D4EQ30392902-9BC4512E-114F-44C1-B2E1-A156BE02F9F9Q30459482-66C086CB-4FEE-4019-90F2-70B9D7BCC3C2Q30473707-D095B15F-D41F-469B-B2B4-FA9C1C986024Q30551483-29B7A9BE-8987-463E-9F86-356D2DEACF37Q33664105-7424739C-3FAA-47F7-BFC1-5AFE7EA6BECAQ33703839-3F90362A-DC2B-4A79-BF23-83179EDEFE97Q33997873-8186B407-48FA-4795-A408-F3A1A4C12762Q34098185-CDE7E96A-1760-454A-AFFF-BD642774704AQ34116825-B1E3912E-64CA-4786-8AA9-F692F37189CCQ34311721-86871D2C-7D1C-400E-AF98-FCB3B5C71999Q34567576-1E91C51A-7124-4F99-B832-201504A12AF1Q34617484-BEB5E3B5-79CF-4F8E-82A4-C04542C8C4CFQ34631608-F331F310-C39C-42A7-939E-6504451086F3Q35107801-9E9C3017-CBEA-4E55-B5BC-697E8309846AQ35112588-5D49FD04-F8AB-497E-91CE-2775994C39C7Q35216481-8D3075C4-7029-4ADE-84FA-DBBA58A1F005Q35532072-63CA282E-79AB-49A9-A6D0-93319599CFC8Q35936413-5F04527F-391D-49C7-B991-10EAABEB71FEQ35982290-FA7C14FE-4B47-492F-9D75-6F6A8088CCF6Q36075529-893891F9-7E46-4964-9F00-277F09676919Q36348362-B6EA1F33-7307-4115-8E73-A2CF45F8F998Q36408464-0BB75781-1EF6-4DEF-A903-134D3D4F72ECQ36496062-04B05839-EF60-4921-8030-4AAFE0E298A9Q36789308-0023035D-A370-4F13-B989-38122703FD69Q36890617-9359ED04-A277-4C9A-B305-1491C913D34EQ36938493-1595DD18-FE9A-49DB-8B18-0E0E9F022285Q36953261-D0E9F207-3EAD-4364-BC96-C28109F01DCDQ37029175-52257C61-F1C6-4C0D-BD4C-8A313A73B216Q37075652-71E0FC01-1D6E-4D72-97E8-3F7883F1B1F3Q37090161-650FAAA7-92DB-4C2F-9313-0701053CEB06
P2860
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@ast
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@en
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@nl
type
label
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@ast
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@en
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@nl
prefLabel
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@ast
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@en
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@nl
P2093
P2860
P921
P3181
P1433
P1476
Brain neuronal CB2 cannabinoid ...... n: from mice to human subjects
@en
P2093
Alex Perchuk
Alicia Brusco
B Emmanuel Akinshola
David Macharia
Eileen Gardner
Emmanuel S Onaivi
George R Uhl
Hiroki Ishiguro
Javier Lujilde
Jian-Ping Gong
P2860
P3181
P356
10.1371/JOURNAL.PONE.0001640
P407
P50
P577
2008-02-20T00:00:00Z